FDA Investigator Douglas Florentino

Douglas Florentino has inspections in 2 countries as of 16 Oct 2023. Douglas Florentino has collaborated with a combinined 3159 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
67
Last Inspection Date:
16 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
100003239
Country:
United States of America, India
Co-Investigator(s):
A Williams, Abby E Pelletier, Abthony C Warchut, Alice C Silva, Alysia M Salonia, Amber G Wardwell, Amy M Fitzpatrick, Ana P Barido, Andrew M Barlow, Andrew R Wasko, Angela E Glenn, Anna M Brannen, Anne E Carpenter, Anthony C Warchut, Anthony N Onianwa, Anthony P Costello, Arie C Menachem, Arindam Dasgupta, PhD, Ashley A Segura, Ashley B Jelonek, Ashley M Whitehurst, Bill Tacket, Jr, Bogdan Kurtyka, Bradley D Newsad, Brenda P King, Brenna L Macdowell, Brunilda Torres, Byungja E Marciante, Camerson E Moore, Carla C Tuite, Carla E Lavallee, CDR Rochelle B Young, RPh, MSA, Celia N Cruz, Charles A Snipes, PhD, Charles R Bonapace, PhD, Charles R Clavet, Christina Capacci Daniel, PhD, Christine L Williams, Christopher J Cruciotti, Christopher K Vantwuyver, Christopher M Elliott, Courtney N Long, Craig A Garmendia, Craig T Rybus, Darin S Wiegers, Daryl A Dewoskin, David P Vanhouten, David R Heiar, Dawn C Olenjack, Debre M Emerson, Diashion E Reid, Douglas Fiorentino Lcdr, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Elizabeth B Griffin, Emily J Schramm, Erich P Garger, Gajendiran Mahadevan, PhD, Garry H Stewart, Gary J Hagan, Gary S Hagan, Gene R Gunn, George T Allen, Jr, Gerald Mierle, Gerard D Difiore, Hien Albright, Holly M Scott, Hugh M Mcclure, II, Irons, Jamie S Mathews, Jana L Caylor, Jason A Rossi, Jason D Tenney, Jennifer L Huntington, Jessica I Newman, John A Sciacchitano, John B Crowe, John L Zaccone, John P Shelton, John R Carlson, Jonathan B Lewis, Joppie, Jose A Torres, Jose R Rodriguez, Joseph B Cascio, Joseph Foley, Joshua J Silvestri, Joshua L Gibbs, Joyce A Kellett, Karen Mcnabb Noon, Kathleen E Mcafoose, Kathleen M Curry, Keith A Schwartz, Kenneth H Williams, Kent A Conforti, Lauren M Lawrance, LCDR Debra Emerson, LCDR Randall L Morris, Leroy Terrelonge, Linda R Kuchenthal, Lindsay R Hatch, Liz M Otero, Lorayne A Mcguinness, LT Richard A Lyght, Lura D Baquero, Lura D Kelly, M Patriciaurphy Murphy, Marcia M Laughrey, Margaret E Walsh, Mark E Farrell, Mark R Mcclain, Martin J Guardia, Mary Jeanet Mcgarry, Matthew C Watson, Megan A Haggerty, Melkamu Getie Kebtie, PhD, Michael J Pasternak, Michael P Anthony, Michael P Sweeney, Michelle M Noe, Michelle M Noe Varga, Mizanne E Lewis, Nichole B Murphy, Nicola M Fenty Stewart, Osama A Khatib, Pamela L Ogonowski, Paraluman S Leonin, Patrick C Klotzbuecher, Paul P Geraci, Peter R Lenahan, Philip H Lafleur, Philip Kreiter, Ramcharan S Khalsa, Robert C Steyert, Robert J Martin, Ronnie E Jackson, Rory K Geyer, Rupa Pradhan, Samina S Khan, Sandra P White, Scott B Laufenberg, Sean M Tessicini, Sean R Marcsisin, Seth A Mailhot, Sharmista Chatterjee, Shawn M Bogdan, Sherbet L Samuels, Shirley S Wen, Slater K Bartlett, Stacey F Allard, Stacey F Rivette, Stacey S Degarmo, State Agency, Susanne M Richardson, MSc RAC ELS, Susanne Mrichardsonmsc Rac, Teddy Tom, Thea C Grome, Thomas J Murphy, Thomas Siebertz, Thomas W Nojek, Timothy C Grome, Troy R Petrillo, Victor J Gangi, Victoria M Daddeo, Victoria Rosales, Victoria Taylor, Vioela J Caze, Wendy A Johnecheck, William K Dagley, Yong Hu

Douglas Florentino's Documents

Publish Date Document Type Title
October, 2010 FDA 483 Pfizer Inc. Groton Laboratories - Form 483, 2010-10-27
December, 2007 FDA 483 Research Packaging, Inc. - Form 483, 2007-12-19
March, 2010 EIR Charles River Laboratories, Inc. - EIR, 2010-03-03
November, 2022 FDA 483 Carlos M. Martinez, M.D. - Form 483, 2022-11-01
July, 2021 FDA 483 A&M Endeavors, LLC - Form 483, 2021-07-14
October, 2009 FDA 483 Radius Medical LLC - Form 483, 2009-10-01

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more